Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Reuters NewMedia - November 1, 2007
"We should caution ourselves that this is still an alarming figure that we must address," Health Minister David Parirenyatwa said in a statement.
Despite years of economic recession, Zimbabwe has become one of the few success spots in battling the AIDS epidemic on the worst affected continent. HIV prevalence has fallen for six years and the figures showed it at 15.6 percent of 15-49 year olds in 2007 compared to 18.1 percent the year before.
Health officials say the drop is the result of government programmes encouraging people to use condoms and have fewer sexual partners. Access to life-saving anti-retroviral drugs has also improved.
The official Herald newspaper quoted Owen Mugurungi, head of Zimbabwe's AIDS and TB unit, as saying the number of people dying of AIDS each week was down to 2,214 from a peak of 2,500 in the late 1990s, when one in four Zimbabweans was infected.
Zimbabwe's drive to increase access to anti-retroviral drugs has been hampered, however, by a severe shortage of foreign currency resulting from the economic crisis.
Of the 1.3 million people living with HIV and AIDS, 86,000 are on anti-retroviral therapy while 260,000 people who need the treatment have no access.
UNICEF said last year Zimbabwe had the world's highest percentage of children orphaned by AIDS, with one in four children having lost at least one parent to the disease.
UNICEF says Zimbabwe continues to lead in the care of the orphans and vulnerable children, with 90 percent of the country's orphans having been absorbed into extended families.
071101
RE071101
Copyright © 2007 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .